Back to search

Netherlands· NL-b1c646edbf25

Ezetimibe/Atorvastatine Althera Laboratories 10 mg/80 mg filmomhulde tabletten

A atorvastatin and ezetimibe product containing atorvastatine calcium 3-water + ezetimib, registered in Netherlands by Althera Laboratories Limited. The same ATC class is registered in 10 of our 19 countries.

ATC C10BA05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEzetimibe/Atorvastatine Althera Labor…ATCC10BA05REGISTER NO.NL-b1c646edbf25PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Atorvastatin and ezetimibe is registered in 10 of 19 countries.

Countries holding a registration under ATC C10BA05 (atorvastatin and ezetimibe), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Atorvastatin and ezetimibe · ATC C10BA05

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ATORVASTATINE CALCIUM 3-WATER + EZETIMIB
Manufacturer
Althera Laboratories Limited
Country
Netherlands (NL)
ATC code
C10BA05
ATC class
Atorvastatin and ezetimibe
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    131660

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for atorvastatin and ezetimibe.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Atorvastatin and ezetimibe · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Atorvastatin and ezetimibe in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atorvastatin and ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Atorvacor + Ezetimib, Atozet
  • Belgium · Atozet, Ezetimibe/Atorvastatin Krka
  • Bulgaria · Аванор Плюс, Зетовар
  • Cyprus · Amicor Plus, Atoritimb
  • Czechia · Amedo Plus, Atoris Plus
  • Germany · Atorimib, Atozet
  • Denmark · Atozet
  • Estonia · Atoritimb, Atorvastatin/Ezetimibe Teva
  • Spain · Atorduo, Atorvastatina/Ezetimiba Cinfa
  • Finland · Ezetimib/Atorvastatin Krka
  • France · Ezetimibe / Atorvastatine Biogaran, Ezetimibe/Atorvastatine Arrow
  • United Kingdom (Northern Ireland) · Atozet
  • Greece · Ancilleg, Ator-Chol Plus
  • Croatia · Altrexyl, Artas Plus
  • Hungary · Atoris Plus, Cholezta
  • Ireland · Atozet, Ezetimibe/Atorvastatin
  • Iceland · Ezetimibe/Atorvastatin Stada
  • Italy · Ancilleg, Athemibe
  • Lithuania · Aterezim, Atorvastatin/Ezetimibe Teva
  • Luxembourg · Atozet, Ezetimib/Atorvastatin Ratiopharm
  • Latvia · Aterezim, Atorvastatin/Ezetimibe Teva
  • Malta · Amicor Plus, Atozet
  • Poland · Coatoris, Ezetimibe + Atorvastatin Sandoz
  • Portugal · Atorduo, Atorvastatina + Ezetimiba Alter
  • Romania · Co-Atoris, Coleatez
  • Sweden · Atozet, Ezetimib/Atorvastatin Krka
  • Slovenia · Aterezim, Ezetimib/Atorvastatin Alkaloid-Int
  • Slovakia · Atoritimb, Atorvastatín/Ezetimib Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a8d061c8-8c31-432a-91db-aea81b83dc0e
GET /v1/drugs/a8d061c8-8c31-432a-91db-aea81b83dc0e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h131660_smpc_en.pdf",
  "strength": null,
  "atc_label": "Atorvastatin and ezetimibe",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg131660",
  "excipients": [
    "CALCIUMCARBONAAT (E 170)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL 4000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "POLYSORBAAT 80 (E 433)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ATORVASTATINE CALCIUM 3-WATER",
    "EZETIMIB"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h131660_piluk.pdf",
  "authorised_at": "2025/09/23",
  "procedure_number": "NL/H/5885/004",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "131660",
  "additional_monitoring": "N"
}

See everything about atorvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.